Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lexeo Therapeutics, Inc. | 10%+ Owner | Common Stock | 1.84M | $24.3M | $13.22 | Nov 7, 2023 | Direct |
IO Biotech, Inc. | Director, 10%+ Owner | Common Stock | 14M | $14.4M | $1.04 | Aug 9, 2023 | Direct |
IO Biotech, Inc. | Director, 10%+ Owner | Warrants (Right to Buy) | 7.9M | Aug 9, 2023 | Direct | ||
Lexeo Therapeutics, Inc. | 10%+ Owner | Series A convertible preferred stock | 0 | Nov 7, 2023 | Direct | ||
Lexeo Therapeutics, Inc. | 10%+ Owner | Series B convertible preferred stock | 0 | Nov 7, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LXEO | Lexeo Therapeutics, Inc. | Nov 7, 2023 | 5 | $2.5M | 4 | Nov 9, 2023 | 10%+ Owner |
LXEO | Lexeo Therapeutics, Inc. | Nov 2, 2023 | 0 | $0 | 3 | Nov 2, 2023 | 10%+ Owner |
IOBT | IO Biotech, Inc. | Aug 9, 2023 | 2 | $16M | 4 | Aug 11, 2023 | Director, 10%+ Owner |
IOBT | IO Biotech, Inc. | Nov 9, 2021 | 5 | $30M | 4 | Nov 12, 2021 | 10%+ Owner |
IOBT | IO Biotech, Inc. | Nov 4, 2021 | 0 | $0 | 3 | Nov 4, 2021 | 10%+ Owner |